IDiyas

For the Inventor, By the Inventor

Hyogo, Japan

Akira Matsushita

USPTO Granted Patents = 15

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 209(Granted Patents)


Location History:

  • Hyogo, JP (1985 - 1995)
  • Kobe, JP (1995)

Company Filing History:

goldMedal14 out of 1,001 
 
Shionogi Company Limited
 patents
silverMedal1 out of 1 
 
Shionigi & Co., Ltd.
 patent

Years Active: 1985-1995

Loading Chart...
15 patents (USPTO):Explore Patents
1. 5461062 - Condensed imidazopyridine derivatives (1995-10-24),
2. 5410058 - Tetrahydropyridine derivatives (1995-04-25),
3. 5378848 - Condensed imidazopyridine derivatives (1995-01-03),
4. 5362873 - Tetrahydropyridine derivatives (1994-11-08),
5. 5243051 - Tetrahydropyridine derivatives (1993-09-07),
6. 5202345 - Carbamoylpyrrolidone derivatives and drugs for senile dementia (1993-04-13),
7. 5149817 - Teirahydropyridine derivatives (1992-09-22),
8. 5120733 - Carbamoylpyrrolidone derivatives and drugs for senile dementia (1992-06-09),
9. 4977167 - Carbamoylpyrolidone derivatives and drugs for senile dementia (1990-12-11),
10. 4940714 - 2-substituted carbonylimidazo[4,5-c]quinolines (1990-07-10),
11. 4923984 - Pyrrolo(1,4)benzodiazepine derivatives (1990-05-08),
12. 4904663 - N-(2-oxpyrrolidin-1-yl-)acetyl)piperazine derivatives and drug for (1990-02-27),
13. 4753951 - Condensed imidazopyridine derivatives useful as psychotropic agents (1988-06-28),
14. 4690930 - Pyrazolo[4,3-c]quinoline-3-one and imidazo[4,3-c]cinnolin-3-one (1987-09-01),
15. 4560684 - 1,4-Benzodiazepine derivatives (1985-12-24),

Title: Akira Matsushita: Innovator in Psychotropic Compounds

Introduction

Akira Matsushita is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of psychotropic agents, holding a total of 15 patents. His work focuses on developing compounds that have potential therapeutic applications.

Latest Patents

Matsushita's latest patents include innovative compounds such as condensed imidazopyridine derivatives. These compounds are characterized by a specific formula where R is an optionally substituted phenyl group, and the A ring is a 5 to 7 membered alicyclic group. These compounds are recognized for their utility as psychotropic agents. Another significant patent involves tetrahydropyridine derivatives, which exhibit high affinity and specificity to sigma receptors, suggesting their effectiveness for certain psychoses.

Career Highlights

Throughout his career, Matsushita has worked with prominent companies, including Shionogi & Company Limited and Shionogi & Co., Ltd. His research and development efforts have contributed to advancements in psychotropic medications.

Collaborations

Matsushita has collaborated with notable colleagues, including Masami Eigyo and Hiromu Matsumura. These partnerships have fostered innovation and enhanced the development of new therapeutic compounds.

Conclusion

Akira Matsushita's work in the field of psychotropic compounds showcases his dedication to advancing medical science. His innovative patents and collaborations highlight his significant impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…